Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study

Journal of Cancer Survivorship

Volumn 10, Issue 4, 2016, Pages 736-742

  Pérez Zepeda, Mario Ulises ^a   Cárdenas Cárdenas, Eduardo ^b   Cesari, Matteo ^c,d   Navarrete Reyes, Ana Patricia ^e   Gutiérrez Robledo, Luis Miguel ^a  

^a INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

^b Hospital 20 de Noviembre   (Mexico)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Chronic disease; Disability; Frailty; Oncogeriatrics

Indexed keywords

AGED; AGING; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; FRAIL ELDERLY; HEALTH STATUS; HUMAN; MALE; MEXICO; NEOPLASM; PREVALENCE; PSYCHOLOGY; SURVIVOR;

AGED; AGING; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FRAIL ELDERLY; HEALTH STATUS; HUMANS; MALE; MEXICO; NEOPLASMS; PREVALENCE; SURVIVORS;

EID: 84957600601     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-016-0519-6     Document Type: Article

References (30)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11. In: GLOBOCAN 2012. http://globocan.iarc.fr. 2012. Accessed 11/04/2015 2015.
2. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94(10):2766–92.
3. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20–37. doi:10.1634/theoncologist.12-1-20.
4. Morley JE, Haren MT, Rolland Y, Kim MJ. Frailty. Med Clin N Am. 2006;90(5):837–47. doi:10.1016/j.mcna.2006.05.019.
5. Rockwood K, Hubbard R. Frailty and the geriatrician. Age Ageing. 2004;33(5):429–30. doi:10.1093/ageing/afh15333/5/429.
6. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.
7. Rouge Bugat ME, Balardy L, Chicoulaa B, Cesari M, Gerard S, Nourashemi F. “Frailty” in geriatry and oncology: one term for two widely differing concepts. J Am Med Dir Assoc. 2014;15(7):528–30. doi:10.1016/j.jamda.2014.04.006.
8. Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol. 2000;35(3):147–54.
9. Cesari M, Colloca G, Cerullo F, Ferrini A, Testa AC, Foti E, et al. Onco-geriatric approach for the management of older patients with cancer. J Am Med Dir Assoc. 2011;12(2):153–9. doi:10.1016/j.jamda.2010.06.008.
10. Mohile SG, Xian Y, Dale W, Fisher SG, Rodin M, Morrow GR, et al. Association of a cancer diagnosis with vulnerability and frailty in older medicare beneficiaries. J Natl Cancer Inst. 2009;101(17):1206–15. doi:10.1093/jnci/djp239.
11. Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hebert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353(9148):205–6. doi:10.1016/S0140-6736(98)04402-X.
12. Cesari M, Gambassi G, van Abellan Kan G, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2014;43(1):10–2.
13. Wong R, Espinoza M, Palloni A. Mexican older adults with a wide socioeconomic perspective: health and aging. Salud Publica Mex. 2007;49 Suppl 4:S436–47.
14. Wong R, Michaels-Obregon A, Palloni A. Cohort profile: the Mexican Health and Aging Study (MHAS). Int J Epidemiol. 2015. doi:10.1093/ije/dyu263.
15. Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. doi:10.1186/1471-2318-8-24.
16. Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62(7):738–43.
17. Lynch SM, George LK. Interlocking trajectories of loss-related events and depressive symptoms among elders. J Gerontol Ser B Psychol Sci Soc Sci. 2002;57:S117–25.
18. Mejia-Arango S, Gutierrez LM. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study. J Aging Health. 2011;23(7):1050–74. doi:10.1177/0898264311421199.
19. Roorda C, Berendsen AJ, Groenhof F, van der Meer K, de Bock GH. Increased primary healthcare utilisation among women with a history of breast cancer. Support Care Cancer. 2013;21(4):941–9. doi:10.1007/s00520-012-1609-2.
20. Smith MR, Saad F, Egerdie B, Sieber PR, Tammela TL, Ke C, et al. Sarcopenia during androgen-deprivation therapy for prostate cancer. J Clin Oncol. 2012;30(26):3271–6. doi:10.1200/JCO.2011.38.8850.
21. Maccormick RE. Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty? Med Hypotheses. 2006;67(2):212–5. doi:10.1016/j.mehy.2006.01.045.
22. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75:685–705. doi:10.1146/annurev-physiol-030212-183653.
23. Kanapuru B, Ershler WB. Inflammation, coagulation, and the pathway to frailty. Am J Med. 2009;122(7):605–13. doi:10.1016/j.amjmed.2009.01.030.
24. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162(20):2333–41.
25. Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, Chen H, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med. 2004;2(1):61–70.
26. Potosky AL, Han KJ, Rowland J, Klabunde CN, Smith T, Aziz N, et al. Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26(12):1403–310. doi:10.1007/s11606-011-1808-4.
27. Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27(29):3338–45. doi:10.1200/JCO.2008.20.4883.
28. Ligibel JA, Denlinger CS. New NCCN guidelines for survivorship care. J Natl Compr Cancer Netw. 2013;11(5 Suppl):640–4.
29. Angelopoulos N, Barbounis V, Livadas S, Kaltsas D, Tolis G. Effects of estrogen deprivation due to breast cancer treatment. Endocr Relat Cancer. 2004;11(3):523–35.
30. Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, et al. Prevalence and factors associated with polypharmacy in older people with cancer. Support Care Cancer. 2014;22(7):1727–34. doi:10.1007/s00520-014-2171-x.